Biogen Inc (BIIB)

Exchange
NASDAQ
Symbol
BIIB
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Country
USA

Stock price

At close: November 20, 2024

  • Open
    155.03
  • High
    156.18
  • Low
    153.62
  • Close
    156.00
  • Volume
    1,630,800

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
2.19
Receivables turnover
5.91
Payables turnover
13.74
Working capital turnover
2.87
Days of inventory on hand (DOH)
166.44
Days of sales outstanding (DSO)
61.75
Number of days of payables
26.56
Fixed asset turnover
2.97
Total asset turnover
0.37
 Liquidity ratios
Current ratio
2.00
Quick ratio
0.91
Cash ratio
0.43
Cash conversion cycle
201.64
 Solvency ratios
Debt-to-assets ratio
0.25
Debt-to-capital ratio
0.31
Debt-to-equity ratio
0.46
Financial leverage ratio
1.81
Interest coverage
6.25
 Profitability ratios
Gross profit margin
43.65%
Operating profit margin
-11.98%
Pretax margin
13.18%
Net profit margin
11.81%
Operating return on assets (Operating ROA)
-4.39%
Return on assets (ROA)
4.33%
Return on total capital
7.15%
Return on equity (ROE)
7.85%